Article info

Download PDFPDF
Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance

Authors

  • Song-Bai Lin International Medical Services, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China PubMed articlesGoogle scholar articles
  • Li Zhou Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China PubMed articlesGoogle scholar articles
  • Zhi-Yong Liang Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China PubMed articlesGoogle scholar articles
  • Wei-Xun Zhou Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China PubMed articlesGoogle scholar articles
  • Ye Jin Clinical Research Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ye Jin, Clinical Research Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing 100730, China; jinye0320{at}me.com
View Full Text

Citation

Lin S, Zhou L, Liang Z, et al
Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance

Publication history

  • Received July 6, 2016
  • Revised January 18, 2017
  • Accepted January 25, 2017
  • First published February 15, 2017.
Online issue publication 
August 22, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.